SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001019056-22-000175
Filing Date
2022-02-11
Accepted
2022-02-11 17:14:02
Documents
2
Group Members
GIL AHARONROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G galera_13g.htm SC 13G 109926
2 EXHIBIT A ex_a.htm EX-99.A 6393
  Complete submission text file 0001019056-22-000175.txt   117936
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91201 | Film No.: 22622664
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: SC 13G